de actualidad

Noticias

Manténgase informado sobre los últimos avances y logros de TRICALS. Aquí informaremos sobre nuestros progresos y sobre los logros de nuestra colaboración a gran escala. Navegue y lea las últimas noticias para mantenerse al tanto durante nuestro viaje para encontrar un tratamiento para la ELA.

ENCALS consensus statement on NurOwn
ENCALS consensus statement on NurOwn
Background Given the interest around the use of stem cells in ALS,…
Manténgase en [u]contacto[/u]

Manténgase en contacto

¿Le gustaría mantenerse al día de las últimas noticias de TRICALS? Haga clic en el siguiente botón para suscribirse a nuestro boletín de noticias

Apellis reports discontinuation of MERIDIAN study
Apellis reports discontinuation of MERIDIAN study
Pharmaceutical company Apellis has announced the discontinuation of the open-label phase of…
Recording of virtual meeting – Adherence and retention in ALS clinical trials
Recording of virtual meeting – Adherence and retention in ALS clinical trials
On March 22, 2023, TRICALS organised its first virtual meeting: ‘Adherence and retention…
COURAGE-ALS trial discontinued due to disappointing results
COURAGE-ALS trial discontinued due to disappointing results
The company Cytokinetics has announced early termination of the COURAGE-ALS study. An…
TRICALS consensus statement on Tofersen
TRICALS consensus statement on Tofersen
OPINION: The consensus view of TRICALS neurologists is that Tofersen shows clear…
El estudio ATLAS: un ensayo clínico para las personas que quieren contribuir con la investigación SOD1-ALS
El estudio ATLAS: un ensayo clínico para las personas que quieren contribuir con la investigación SOD1-ALS
Biogen está llevando a cabo un ensayo clínico para evaluar la eficacia…
Measuring treatment effects based on patient preference
Measuring treatment effects based on patient preference
To evaluate the effect of an investigational drug in ALS clinical trials,…
TRICALS Enrols First Participants in Phase 3 MAGNET platform trial for ALS
TRICALS Enrols First Participants in Phase 3 MAGNET platform trial for ALS
TRICALS (the Treatment Research Initiative to Cure ALS), in collaboration with ALS…
USA: new law promises $100 million for ALS research
USA: new law promises $100 million for ALS research
A new law has been passed in the United States to give…
Congratulations to our TRICALS colleagues as UK Government invests £50 million to find a cure for ALS
Congratulations to our TRICALS colleagues as UK Government invests £50 million to find a cure for ALS
The UK government has recently announced that £50 million will be invested…